Synthesis and preliminary pharmacological screening of novel imidazo[2,1-f]theophylline derivatives

Farmaco

Volumn 57, Issue 9, 2002, Pages 697-702

  Pawlowski, Maciej ^a   Katlabi, Jacek ^a   Jurczyk, Slawomir ^a   Malec, Danuta ^b   Modzelewski, Jerzy ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CNS activity of fused 2,1 f theophyllines; Imidazo 2,1 f theophyllines

Indexed keywords

8 BENYZL 6,7 DIHYDRO (8H) IMIDAZO[2,1 F]THEOPHYLLINE 7 CARBOXYLIC ACID (2 N,N DIMETHYLAMINE ETHYL)AMIDE; 8 BENYZL 6,7 DIHYDRO (8H) IMIDAZO[2,1 F]THEOPHYLLINE 7 CARBOXYLIC ACID (MORPHINE PROPYL)AMIDE; 8 BENZYL 6,7 DIHYDRO (8H) IMIDAZO[2,1 F]THEOPHYLLINE 7 CARBOXYLIC ACID (2 N,N DIETHYLAMINE PROPYL)AMIDE; 8 BENZYL 6,7 DIHYDRO (8H) IMIDAZO[2,1 F]THEOPHYLLINE 7 CARBOXYLIC ACID (3 ETHOXYPROPYL)AMIDE; 8 BENZYL 6,7 DIHYDRO (8H) IMIDAZO[2,1 F]THEOPHYLLINE 7 CARBOXYLIC ACID (3 METHOXYPROPYL)AMIDE; 8 BENZYL 6,7 DIHYDRO (8H) IMIDAZO[2,1 F]THEOPHYLLINE 7 CARBOXYLIC ACID ETHYL ESTER; AMPHETAMINE; APOMORPHINE; CARBOXYLIC ACID DERIVATIVE; PENTETRAZOLE; SEROTONIN ANTAGONIST; THEOPHYLLINE DERIVATIVE; UNCLASSIFIED DRUG; CENTRAL STIMULANT AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; THEOPHYLLINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTICONVULSANT ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SYNTHESIS; LOCOMOTION; MALE; NONHUMAN; RAT; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; MOTOR ACTIVITY; MOUSE; SEIZURE; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

AMPHETAMINE; ANIMALS; APOMORPHINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE AGONISTS; DRUG ANTAGONISM; DRUG EVALUATION, PRECLINICAL; MICE; MOTOR ACTIVITY; SEIZURES; STRUCTURE-ACTIVITY RELATIONSHIP; THEOPHYLLINE;

EID: 0036753669     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(02)01224-7     Document Type: Article

References (15)

1. Pawlłowski M., Drabczyńska A., Gorczyca M., Malec D., Modzelewski J. Synthesis and preliminary pharmacological assessment of novel 9-substituted pyrimidino[2,1-f]purines. Pol. J. Pharmacol. Pharm. 43:1991;61-70. C.A. 116; 34326q, 1992.
2. Drabczyńska A., Pawlłowski M., Gorczyca M., Malec D., Modzelewski J. Synthesis and preliminary pharmacological assessment of novel 9-alkylamino substituted pyrimidino[2,1-f]purines. Pol. J. Pharmacol. Pharm. 44:1992;487-503. C.A. 119; 195099v; 1993.
3. Pawlłowski M., Drabczyńska A., Gorczyca M., Malec D., Modzelewski J. Synthesis and pharmacological screening of novel 10-substituted diazepino[2,1-f]purines. Acta Polon. Pharm. 51:1994;385-391. C.A. 123; 143853z; 1995.
4. Pawlłowski M., Drabczyńska A., Gorczyca M., Malec D., Modzelewski J. Chemical and pharmacological properties of new tetrahydropyrimido[2,1-f]purines. Pharmazie. 50:1995;453-455.
5. Pawlłowski M., Drabczyńska A., Katlabi J., Gorczyca M., Malec D., Modzelewski J. Synthesis and CNS activity of tricyclic theophylline derivatives. 8-Substituted imidazo[2,1-f]theophyllines. Eur. J. Med. Chem. 34:1999;1085-1091.
6. 1A receptor antagonist of the 1-arylpiperazine class of ligands. Eur. J. Med. Chem. 30:1995;587-592.
7. 1A agonistic activity. Eur. J. Med. Chem. 34:1999;167-175.
8. 2A receptor affinity of new 1-phenylpiperazinylpropyl derivatives of purine-2,6- and pyrrolidine-2,5-diones. Farmaco. 55:2000;461-468.
9. Pawlłowski M., Katlabi J., Rys B., Szneler E. New tricyclic theophylline derivatives. Reaction of 8-benzylaminotheophylline with ethyl 2,3-dibromopropanoate. Pharmazie. 52:1995;279-282.
10. Gorczyca M., Pawlłowski M., Ryznerski Z. Synthesis and properties of 7-hydroxyalkyl-8-benzylaminotheophyllines. Pol. J. Pharmacol. Pharm. 27:1975;305-309. C.A. 83; 178999j; 1975.
11. Pawlłowski M., Gorczyca M. Synthesis and properties of 7-hydroxyalkyl- and 7-hydroxyalkylamino-8-benzylaminotheophylline derivatives. Pol. J. Pharmacol. Pharm. 32:1980;779-788. C.A. 95; 97737t; 1981.
12. Litchfield L.T., Wilcoxon F. A simplified method of evaluating dose effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
13. Gross F., Tripod J., Meier R. Zur Pharmakologieschen Charakterisierung des Schlafmittels Doriden. Schweiz. Med. Wochschr. 85:1955;305-309.
14. Costall B., Naylor R.J. Mesolimbic involvement with behavioral effects indicating antipsychotic activity. Eur. J. Pharmacol. 27:1974;46-58.
15. Corne S.J., Pickering R.W., Werner B.T. A method for assessing the effects of drugs on the central action of 5-hydroxytryptamine. Br. J. Pharm. 20:1963;106-120.